HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisResearch in context
Summary: Background: Glatiramer acetate (GA) is a well-tolerated treatment for multiple sclerosis (MS) and comparable in its efficacy to high-dose interferon beta (IFN). As a lack of validated treatment response biomarkers for MS hampers progress in personalised treatment, the study goal was to sea...
Saved in:
Similar Items
-
Incremental Capacity and Voltammetry of Batteries, and Implications for Electrochemical Impedance Spectroscopy
by: Christopher Dunn, et al.
Published: (2025-06-01) -
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
by: Valerie A J Block, et al.
Published: (2016-01-01) -
Selective digestive tract decontamination in the intensive care unit: Life saver or recipe for disaster?
by: J.S. Davis, et al.
Published: (2025-06-01) -
Sociology for Social Workers and Probation Officers /
by: Cree, Viviene E., 1954-
Published: (2010) -
Microalgae: A Promising Source of Bioactive Polysaccharides for Biotechnological Applications
by: Chiara Magnabosco, et al.
Published: (2025-05-01)